Navigation Links
New drug for hypertension

The National Chemical Laboratory (NCL) and Emcure Pharmaceuticals Ltd, a Pune-based company have jointly come out with a new drug for the treatment of hypertension. Announcing this at a press conference here on Thursday,// NCL director Sivaram and Emcure managing director Satish Mehta said the chirally pure S-Amlodipine, a product of their collaborative research, will be a great boon for the patients suffering from hypertension.

Stating that Emcure is among the first few in the world to introduce this product, they said the company has been granted permission from Drug Controller General of India for the manufacture of both bulk as well as formulations of S-Amlodipine.

Although Amlodipine is a proven therapy for the treatment of hypertension, it is commonly associated with side effects like headache, dizziness, flusing and abdominal pain, they said.But clinical study of S-Amlodipine has shown that none of the patients in the treatment group reported any such side effects, they said adding, NCL has already filed Indian and foreign patent applications. S-Amlodipine is the first of many more chirally pure drugs on which the NCL and Emcure scientists are working, they added.


'"/>




Page: 1

Related medicine news :

1. Preventing white coat hypertension
2. Risk of dementia reduced hypertension drugs
3. An hour of exercise a week cuts hypertension
4. Drug used to treat hypertension effective in countering Migraines
5. Common, cheaper drugs could be used to treat hypertension
6. Evidence against use of Beta blockers as first choice in the treatment of primary hypertension
7. Healthy lifestyle reduces the risk of developing hypertension
8. Prehypertension in the Young Leads to Hypertensive Adults
9. Hypertension, Prehypertension in Youngsters Linked With Heart Enlargement
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer ... through a fitness app. The fitness app plans to fix the two major problems leading ... a one size fits all type program , They don’t eliminate all the ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: